VGM, Leitten update bid study
By HME News Staff
Updated 10:35 AM CDT, Tue October 19, 2021
.jpg)
WATERLOO, Iowa – VGM Government Relations, in conjunction with Brian Leitten and Leitten Consulting, has released an updated study analyzing efforts by CMS to control distribution of DME. The study, “Competitive Bidding – A Decade Focused on the Wrong Prize. The Case for Medicare Investment in DME in 2021,” looks at how competitive bidding generated savings and reduced fraud but missed an even larger opportunity to invest in DME. “The costs that CMS saved over a decade of focusing on the wrong prize pale in comparison to the real prize: reducing the cost of treating injuries and illnesses that befall Medicare beneficiaries who lack the critical DME they need to stay well,” said Brian Leitten, head of Leitten Consulting. “CMS continues to bear this enormous cost, which has constantly grown over the decade and now stands at an estimated total of $98 billion annually in three DME categories: mobility DME, oxygen therapy and CPAP therapy equipment and supplies.” VGM first engaged Leitten Consulting in 2010 to examine the costs associated with falls, COPD and OSA, and how investing in DME could save billions annually. The study, paid for by Last Chance for Patients Choice, has been updated every few years.
Comments